Clinical Outcome and B Cell Depletion in Patients with Rheumatoid Arthritis Receiving Rituximab Monotherapy in Comparison with Patients Receiving Concomitant Methotrexate
Overview
Affiliations
Rituximab for the treatment of multiple sclerosis: a review.
Chisari C, Sgarlata E, Arena S, Toscano S, Luca M, Patti F J Neurol. 2021; 269(1):159-183.
PMID: 33416999 PMC: 7790722. DOI: 10.1007/s00415-020-10362-z.
Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders.
Kaegi C, Wuest B, Schreiner J, Steiner U, Vultaggio A, Matucci A Front Immunol. 2019; 10:1990.
PMID: 31555262 PMC: 6743223. DOI: 10.3389/fimmu.2019.01990.
Biologic monotherapy in the treatment of rheumatoid arthritis.
Detert J, Klaus P Biologics. 2015; 9:35-43.
PMID: 26028960 PMC: 4440355. DOI: 10.2147/BTT.S53361.
Rituximab for rheumatoid arthritis.
Lopez-Olivo M, Amezaga Urruela M, McGahan L, Pollono E, Suarez-Almazor M Cochrane Database Syst Rev. 2015; 1:CD007356.
PMID: 25603545 PMC: 11115378. DOI: 10.1002/14651858.CD007356.pub2.
Wendler J, Burmester G, Sorensen H, Krause A, Richter C, Tony H Arthritis Res Ther. 2014; 16(2):R80.
PMID: 24670196 PMC: 4060207. DOI: 10.1186/ar4521.